These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Recommended use of INR in the laboratory monitoring of oral anticoagulant treatment]. Syrjälä M Duodecim; 1998; 114(6):573-5. PubMed ID: 11466922 [No Abstract] [Full Text] [Related]
8. [Anticoagulant treatment of patient with the substitute heart valve]. Halinen MO; Lassila R Duodecim; 2000; 116(2):157-65. PubMed ID: 11764475 [No Abstract] [Full Text] [Related]
9. Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Siebenhofer A; Rakovac I; Kleespies C; Piso B; Didjurgeit U Thromb Haemost; 2007 Mar; 97(3):408-16. PubMed ID: 17334508 [TBL] [Abstract][Full Text] [Related]
11. Comparison of oral versus intravenous phytonadione in patients with excessive anticoagulation. Key N Curr Hematol Rep; 2004 Sep; 3(5):315-6. PubMed ID: 15341696 [No Abstract] [Full Text] [Related]
12. [Anticoagulation by oral treatment with vitamin K antagonists]. Kemkes-Matthes B Hamostaseologie; 2008 Dec; 28(5):421-7. PubMed ID: 19132171 [TBL] [Abstract][Full Text] [Related]
13. Application of the theory of planned behavior to oral anticoagulant therapy. Burns S Nurs Health Sci; 2009 Mar; 11(1):98-101. PubMed ID: 19298315 [TBL] [Abstract][Full Text] [Related]
14. Self-monitoring versus standard monitoring of oral anticoagulation. Ferretti G; Giannarelli D; Carlini P; Felici A; Ciccarese M; Mandalà M; Cognetti F Thromb Res; 2007; 119(3):389-90. PubMed ID: 17023029 [No Abstract] [Full Text] [Related]
15. Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases. Turpie AG Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1238-47. PubMed ID: 17379841 [TBL] [Abstract][Full Text] [Related]
16. [From Quick's percentage to the INR (International Normalized Ratio)--a real advance in the control of oral anticoagulation]. Beck EA Schweiz Med Wochenschr; 1985 Oct; 115(40):1378-80. PubMed ID: 4071012 [No Abstract] [Full Text] [Related]
17. Antibacterial prescribing and warfarin: a review. Rice PJ; Perry RJ; Afzal Z; Stockley IH Br Dent J; 2003 Apr; 194(8):411-5. PubMed ID: 12778089 [No Abstract] [Full Text] [Related]
18. Improving the quality of anticoagulant therapy in patients with mechanical heart valves: what are we waiting for? Herijgers P; Verhamme P Eur Heart J; 2007 Oct; 28(20):2424-6. PubMed ID: 17890728 [No Abstract] [Full Text] [Related]
19. A preliminary assessment of the critical differences between novel oral anticoagulants currently in development. McBride BF J Clin Pharmacol; 2005 Sep; 45(9):1004-17. PubMed ID: 16100294 [TBL] [Abstract][Full Text] [Related]
20. Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy. McGlasson DL; Romick BG; Rubal BJ Blood Coagul Fibrinolysis; 2008 Sep; 19(6):513-7. PubMed ID: 18685434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]